Postauthorization safety study of Clottafact®, a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study.

Autor: Négrier, C.1, Ducloy‐Bouthors, A.‐S.2, Piriou, V.3, De Maistre, E.4, Stieltjes, N.5, Borel‐Derlon, A.6, Colson, P.7, Picard, J.8, Lambert, T.9, Claeyssens, S.10, Boileau, S.11, Bertrand, A.12, André, M.‐H.12, Fourrier, F.2, Ozier, Y.13, Sié, P.14, Gruel, Y.15, Tellier, Z.12 tellier@lfb.fr
Zdroj: Vox Sanguinis. Feb2018, Vol. 113 Issue 2, p120-127. 8p. 5 Charts.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje